Skip to main content
Search
Site Search
United Kingdom | en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Brazil |
Português
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Mexico |
Español
(link is external)
United States |
English
(link is external)
Australia |
English
(link is external)
Bangladesh |
English
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Mainland China |
中文
(link is external)
Malaysia |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Singapore |
English
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Austria |
Deutsch
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Bulgaria |
Български
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hungary |
Magyar
(link is external)
Ireland |
English
(link is external)
Italy |
Italiano
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Serbia |
Srpski
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Türkiye |
Türkçe
(link is external)
United Kingdom |
English
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Egypt |
English
(link is external)
Israel |
עברית
(link is external)
Saudi Arabia |
العربية
(link is external)
South Africa |
English
(link is external)
United Kingdom
Choose Location
europe
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Australia |
English
(link is external)
Austria |
Deutsch
(link is external)
Bangladesh |
English
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Brazil |
Português
(link is external)
Bulgaria |
Български
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Egypt |
English
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
Hungary |
Magyar
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Ireland |
English
(link is external)
Israel |
עברית
(link is external)
Italy |
Italiano
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Mainland China |
中文
(link is external)
Malaysia |
English
(link is external)
Mexico |
Español
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Saudi Arabia |
العربية
(link is external)
Serbia |
Srpski
(link is external)
Singapore |
English
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
South Africa |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Türkiye |
Türkçe
(link is external)
United Kingdom |
English
United States |
English
(link is external)
Menu
About
Novartis in the UK
Partnerships
Collaborative working
External funding
Patient group partnership
Sponsorships
Diseases
Strategy
People and culture
Who we are
About
Patients and caregivers
External funding
Patient group partnership
Patients and Caregivers
Healthcare professionals
For UK healthcare professionals
(link is external)
Healthcare Professionals
ESG
Ethical behaviour
Code of Ethics
Speakup
Ethics, risk and compliance
Access
Environmental sustainability
Global health
Transparency
Healthcare professional payment transparency
Health inequalities
ESG
News
Stories
News archive
Novartis UK press office
News
Careers
Career search
Personal growth
(link is external)
Early talent
(link is external)
How we work
(link is external)
Well-being
Career programmes
(link is external)
Awards and recognition
(link is external)
Careers
Contact
Home
Home
News
News archive
News archive
The UK News Archive contains resources intended for journalists only.
Date Range
- Any -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- Any -
English
Start Date
End Date
News Archive Navigation
News Archive Navigation
All
Show More Links
Media Release
Stories
icon
List View
Showing 4 results
February 2025
Media Release
Feb 04, 2025
Novartis Kisqali® (ribociclib) receives MHRA authorisation for the adjuvant treatment of HR+/HER2- early breast cancer at high risk of recurrence in a broad population of patients
The Medicines and Healthcare products Regulatory Agency (MHRA) have authorised a new indication for ribociclib as an adjuvant treatment option to be used in combination with an aromatase inhibitor (…
January 2025
Media Release
Jan 13, 2025
Adults in Scotland with rare blood disorder to get access to new oral monotherapy on NHS
Scottish Medicines Consortium (SMC) has recommended Fabhalta®▼ (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the…
September 2024
Media Release
Sep 04, 2024
Adults in England and Wales with rare blood disorder to get access to new oral monotherapy on NHS
The National Institute for Health and Care Excellence (NICE) has published final guidance (TA1000) recommending Fabhalta®▼(iptacopan) as a treatment option in eligible patients on the NHS in England…
July 2023
Story
Jul 17, 2023
Education & Awareness
New Get Back in the Game documentary with Mark Ramprakash on cholesterol
Pagination
All
Last 7 Days
Last 30 Days
Last 6 months
Custom
Cancel
Apply